D.Th. Sleijfer
- Reproductive Medicine top 2%
- Ovarian cancer diagnosis and treatment 10
- Oncology top 5%
- Neutropenia and Cancer Infections 6
- Surgery top 5%
- Testicular diseases and treatments 29
- Hematology top 5%
- Neurology top 5%
-
- Chemotherapy-induced organ toxicity mitigation 8
-
- Sarcoma Diagnosis and Treatment 7
-
- Chemotherapy-related skin toxicity 6
-
- Urologic and reproductive health conditions 6
-
- Cancer therapeutics and mechanisms 5
- Co-authors
- Elisabeth G.E. de VriesH. Schraffordt KoopsNanno H. MulderPax H.B. WillemseJourik A. GietemaHarm HoekstraWinette T.A. van der GraafNH Mulder
- Cited by
- Reproductive MedicineOncologySurgery
- Journals
- British Journal of Cancer (8 papers)Journal of Clinical Oncology (8 papers)European Journal of Cancer (6 papers)
- Partner nations
- NetherlandsUnited KingdomUnited States
In The Last Decade
D.Th. Sleijfer
72 papers receiving 1.9k citations
Peers
Comparison fields: 5 of 107
- Reproductive Medicine 401
- Oncology 687
- Surgery 893
- Hematology 198
- Neurology 214
Countries citing papers authored by D.Th. Sleijfer
This map shows the geographic impact of D.Th. Sleijfer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by D.Th. Sleijfer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites D.Th. Sleijfer more than expected).
Fields of papers citing papers by D.Th. Sleijfer
This network shows the impact of papers produced by D.Th. Sleijfer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by D.Th. Sleijfer. The network helps show where D.Th. Sleijfer may publish in the future.
Co-authorship network
The 25 scholars most cited alongside D.Th. Sleijfer, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 75 | |
| 2 | 2004 | 57 | |
| 3 | 2004 | 46 | |
| 4 | 2002 | 3 | |
| 5 | Completing logbooks: when and how | 2001 | 0 |
| 6 | 2001 | 3 | |
| 7 | 1998 | 26 | |
| 8 | 1997 | 27 | |
| 9 | 1997 | 17 | |
| 10 | 1995 | 9 | |
| 11 | 1995 | 10 | |
| 12 | 1994 | 13 | |
| 13 | 1993 | 2 | |
| 14 | 1992 | 73 | |
| 15 | 1991 | 6 | |
| 16 | 1990 | 28 | |
| 17 | 1989 | 24 | |
| 18 | 1987 | 54 | |
| 19 | 1984 | 6 | |
| 20 | 1983 | 3 |
About D.Th. Sleijfer
D.Th. Sleijfer is a scholar working on Reproductive Medicine, Oncology and Surgery, having authored 74 papers that have together received 2.1k indexed citations. Recurring topics across this work include Testicular diseases and treatments (29 papers), Ovarian cancer diagnosis and treatment (10 papers), Chemotherapy-induced organ toxicity mitigation (8 papers), Sarcoma Diagnosis and Treatment (7 papers), Chemotherapy-related skin toxicity (6 papers), Neutropenia and Cancer Infections (6 papers), Urologic and reproductive health conditions (6 papers) and Cancer therapeutics and mechanisms (5 papers). The work is most often cited by research in Reproductive Medicine (401 citations), Oncology (687 citations) and Surgery (893 citations). D.Th. Sleijfer has collaborated with scholars based in Netherlands, United Kingdom and United States. Frequent co-authors include Elisabeth G.E. de Vries, H. Schraffordt Koops, Nanno H. Mulder, Pax H.B. Willemse, Jourik A. Gietema, Harm Hoekstra, Winette T.A. van der Graaf, NH Mulder, N. H. Mulder and Pieter E. Postmus. Their work appears in journals such as British Journal of Cancer, Journal of Clinical Oncology, European Journal of Cancer, Annals of Oncology and Gynecologic Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.